No abstract available
Keywords:
Anaemia; Cardiovascular safety; Ferric carboxymaltose; Functional outcome; Intravenous iron; Iron deficiency.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Anemia, Iron-Deficiency / blood
-
Anemia, Iron-Deficiency / diagnosis
-
Anemia, Iron-Deficiency / drug therapy*
-
Female
-
Ferric Compounds / administration & dosage*
-
Ferric Compounds / adverse effects
-
Follow-Up Studies
-
Heart Failure / blood
-
Heart Failure / diagnosis
-
Heart Failure / drug therapy*
-
Humans
-
Infusions, Intravenous
-
Male
-
Maltose / administration & dosage
-
Maltose / adverse effects
-
Maltose / analogs & derivatives*
-
Middle Aged
-
Prognosis
-
Treatment Outcome
-
Ventricular Dysfunction, Left / blood
-
Ventricular Dysfunction, Left / diagnosis
-
Ventricular Dysfunction, Left / drug therapy*
Substances
-
Ferric Compounds
-
ferric carboxymaltose
-
Maltose